Back to VANGUARD GROUP INC VANGUARD GROUP INC

REGNREGN
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in REGENERON PHARMACEUTICALS

VANGUARD GROUP INC holds 9.1M shares of REGN (REGENERON PHARMACEUTICALS), worth $7B as of 2025-Q4. The position was increased (+0.3% shares). REGN represents 0.1% of VANGUARD GROUP INC's portfolio.

Current Value

$7B

Current Shares

9.1M

Total Value Change

-$2.8B

Total Shares Change

-245,137

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
9.1M
+0.3%
$7B0.1%$773.94
38
2025-Q3
Decreased
9M
-4.0%
$5.1B0.1%$560.05
0
2025-Q2
Increased
9.4M
+0.2%
$4.9B0.1%$519.56
32
2025-Q1
Increased
9.4M
+1.3%
$6B0.1%$634.66
39
2024-Q4
Decreased
9.3M
-0.4%
$6.6B0.1%$698.71
0
2024-Q3
New
9.3M
-
$9.8B0.2%$1,036.94
53

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used